Saltar al contenido

Amgen Inc (AMGN) stock: revenue, earnings & dividend

Amgen Inc (AMGN, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener AMGN · Nasdaq Pharma & Biotech US-CA

Key figures

Fiscal year
2025
Revenue
36.8 bn $
Revenue growth
10 %
Revenue growth 5y (p.a.)
7.7 %
Net income
7.71 bn $
Net margin
21 %
Operating margin
24.7 %
Earnings per share (diluted)
14.23 $
Dividend per share
9.66 $
Payout ratio
67.9 %
Consecutive dividend years
10 years
Consecutive dividend raises
9 years
Dividend growth 5y (p.a.)
8.1 %
Total assets
90.6 bn $
Equity
8.66 bn $
Equity ratio
9.6 %
Return on equity
89.1 %
Cash
9.13 bn $
Operating cash flow
9.96 bn $
Free cash flow
8.1 bn $
Shares outstanding
540,911,490

History

Revenue by fiscal year

2016 23 bn $
2017 22.8 bn $
2018 23.7 bn $
2019 23.4 bn $
2020 25.4 bn $
2021 26 bn $
2022 26.3 bn $
2023 28.2 bn $
2024 33.4 bn $
2025 36.8 bn $

Net income by fiscal year

2016 7.72 bn $
2017 1.98 bn $
2018 8.39 bn $
2019 7.84 bn $
2020 7.26 bn $
2021 5.89 bn $
2022 6.55 bn $
2023 6.72 bn $
2024 4.09 bn $
2025 7.71 bn $

Dividend per share

2016 4.15 $
2017 4.77 $
2018 5.41 $
2019 5.95 $
2020 6.56 $
2021 7.22 $
2022 7.95 $
2023 8.64 $
2024 9.13 $
2025 9.66 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202536.8 bn $7.71 bn $14.23 $9.66 $9.96 bn $
202433.4 bn $4.09 bn $7.56 $9.13 $11.5 bn $
202328.2 bn $6.72 bn $12.49 $8.64 $8.47 bn $
202226.3 bn $6.55 bn $12.11 $7.95 $9.72 bn $
202126 bn $5.89 bn $10.28 $7.22 $9.26 bn $
202025.4 bn $7.26 bn $12.31 $6.56 $10.5 bn $
201923.4 bn $7.84 bn $12.88 $5.95 $9.15 bn $
201823.7 bn $8.39 bn $12.62 $5.41 $11.3 bn $
201722.8 bn $1.98 bn $2.69 $4.77 $11.2 bn $
201623 bn $7.72 bn $10.24 $4.15 $10.4 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)